Ramsay Santé

61 currently recruiting clinical trials

Phase 3 Prostate cancer #NCT05116475 #2024-517285-41-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Hormone-sensitive
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Privé des Peupliers - Ramsay Santé (Paris)
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Phase 3 Prostate cancer #NCT06276465 #2023-507482-26-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery Radiotherapy
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy
Hôpital Privé Clairval - Ramsay Santé (Marseille)
UNICANCER
Phase 3 Breast cancer #NCT06312176
Required HER2 statuses
HER2 Negative
Required HR statuses
HR Positive
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Targeted therapy Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive Chemotherapy
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Merck Sharp & Dohme LLC
Phase 3 Liver and bile duct cancer #NCT06813976
Required histologic sub types
Ampullary carcinoma
Required disease stage
Localized
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery
Hôpital privé d'Antony - Ramsay Santé (Antony), Clinique de la Sauvegarde - Ramsay Santé (Lyon), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
CHU Dijon
Phase 3 Pancreas cancer #NCT00268411
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Chemotherapy Radiotherapy
Excluded previous treatments at advanced or metastatic stage
Chemotherapy Radiotherapy
Polyclinique du Parc Drevon - Ramsay Santé (Dijon)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 3 Breast cancer #NCT06393374
Required HER2 statuses
HER2 Negative
Required HR statuses
HR Negative
Required disease stage
Localized Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery Immunotherapy Chemotherapy
Required previous treatments at advanced or metastatic stage
Surgery Immunotherapy Chemotherapy
Excluded genetic anomalies
BRCA 1/2
Excluded previous treatments at localized stage
Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence)
Merck Sharp & Dohme LLC
Phase 3 Rectal cancer #NCT06762405
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized Locally Advanced
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at localized stage
Immunotherapy Chemotherapy Radiotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy Radiotherapy
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
CHU Dijon
Phase 2 / Phase 3 Lung cancer #NCT05255302 #2024-515945-40-00
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required histologic sub types
Squamous NSCLC Non-squamous NSCLC
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
ALK EGFR HER2 NTRK-1/2/3 RET ROS-1 Other mutation
Excluded previous treatments at localized stage
Immunotherapy Chemotherapy
Excluded previous treatments at advanced or metastatic stage
Immunotherapy Chemotherapy Targeted therapy
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2 / Phase 3 Colon cancer Rectal cancer #NCT05462613 #2024-516709-22-00
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Surgery Chemotherapy Targeted therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon)
CHU de Besançon
Phase 2 Pancreas cancer Stomach and esophageal cancer #NCT04325425 #2024-515300-39-00
Required histologic types
Stomach
Required histologic sub types
Neuroendocrine carcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Chemotherapy Targeted therapy
Hôpital Privé Sainte Marie - Ramsay Santé (Chalon-sur-Saône), Hôpital privé d'Antony - Ramsay Santé (Antony)
CHU Dijon